Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 Neuroblastoma.

about

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma.

P2860

Q55127179-F825F51D-A5F8-4490-B91F-F622C7438D21

P2860

Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 Neuroblastoma.

Item

http://www.wikidata.org/entity/Q36908714

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Outcomes After Radiation Thera ...... ts With Stage 4 Neuroblastoma.

@en

type

Item

label

Outcomes After Radiation Thera ...... ts With Stage 4 Neuroblastoma.

@en

prefLabel

Outcomes After Radiation Thera ...... ts With Stage 4 Neuroblastoma.

@en

P1476

Outcomes After Radiation Thera ...... nts With Stage 4 Neuroblastoma

@en

P2093

Howard Katzenstein

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Switchenko

http://www.w3.org/2001/XMLSchema#string

Muna Qayed

http://www.w3.org/2001/XMLSchema#string

Ronica Nanda

http://www.w3.org/2001/XMLSchema#string

Roshan S Prabhu

http://www.w3.org/2001/XMLSchema#string

Shravan Kandula

http://www.w3.org/2001/XMLSchema#string

Thomas Cash

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.

Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience.

Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.

Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.

Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission

Role of palliative radiotherapy in the management of metastatic pediatric neuroblastoma: a retrospective single-institution study.

Palliative radiotherapy in children with neuroblastoma.

P304

175-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MPH.0000000000000264

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Natia Esiashvili

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25238225

http://www.w3.org/2001/XMLSchema#string

P932

4869887

http://www.w3.org/2001/XMLSchema#string

Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 Neuroblastoma.

about

P2860

P2860

Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 Neuroblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932